Cargando…
Challenges in Repurposing Drugs in COVID-19 Pandemic. Debating on Potential New Refinements
Autores principales: | Frega, Giorgio, Palloni, Andrea, Di Pasquale, Giuseppe, Saccoccio, Gioconda, Rizzo, Alessandro, Poluzzi, Elisabetta, Iannone, Primiano, Brandi, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7655924/ https://www.ncbi.nlm.nih.gov/pubmed/33192506 http://dx.doi.org/10.3389/fphar.2020.559996 |
Ejemplares similares
-
Sustained complete response of advanced hepatocellular carcinoma with metronomic capecitabine: a report of three cases
por: Brandi, Giovanni, et al.
Publicado: (2018) -
Targeting BRAF-Mutant Biliary Tract Cancer: Recent Advances and
Future Challenges
por: Rizzo, Alessandro, et al.
Publicado: (2020) -
Predictive Biomarkers for Checkpoint Inhibitor-Based Immunotherapy in Hepatocellular Carcinoma: Where Do We Stand?
por: Rizzo, Alessandro, et al.
Publicado: (2021) -
Adjuvant treatment in biliary tract cancer
por: Palloni, Andrea, et al.
Publicado: (2019) -
Molecular Features and Targeted Therapies in Extrahepatic Cholangiocarcinoma: Promises and Failures
por: Rizzo, Alessandro, et al.
Publicado: (2020)